Fig 2. Viability of human islets treated with or without C3G and with or without amylin or Aβ1-42.
(A) Islets stained with calcein (green, live), ethidium (red, dead), and DAPI (blue, nuclei). Representative untreated, amylin-treated, Aβ1-42-treated, C3G-treated, C3G + amylin-treated, C3G + Aβ1-42-treated islets are shown. Scale bar represents 20μm. (B) Percentage of viability in untreated or C3G-treated islets exposed to amylin or Aβ1-42 (*p<0.001, untreated vs. amylin; *p<0.01, untreated vs. Aβ1-42; n = 4–5; +p<0.05, amylin vs. C3G + amylin; +p<0.05, Aβ1-42 vs. C3G + Aβ1-42; n = 4).